berita terbaru Indonesia, analisis | Latest breaking Indonesian news headlines

Techstars Tokyo Accelerator Announces Inaugural Class of 2024

TOKYO, Aug 22, 2024 – (JCN Newswire via SeaPRwire.com) – Techstars Tokyo Accelerator powered by JETRO and Mitsui Fudosan is proud to announce the 12 startups selected for the Class of 2024. These promising, early-stage companies are addressing challenges in categories such as Women’s Health, Gaming, Animation, Productivity Enhancement, B2B Business Intelligence, Robotics and more. […]

Mitsubishi Ralliart’s Triton Finishes in Fifth Place Overall in Asia Cross Country Rally 2024: Team Determined to Make a Comeback Next Year

TOKYO, Aug 21, 2024 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that Team Mitsubishi Ralliart, for which the company provides technical support, has won fifth place overall in the Asia Cross Country Rally (hereafter, AXCR) 2024, held in Thailand from August 11 to 17, with the Triton1 (T1 specification, […]

Valuufy Established to Transform Sustainable Business and Investing

KYOTO, JAPAN, Aug 14, 2024 – (JCN Newswire via SeaPRwire.com) – Valuufy, a pioneering fintech startup drawn from a decades’ work in measuring and creating sustainable value at Doshisha University’s Value Research Center, has launched with its groundbreaking ValuuCompass, a comprehensive framework set to transform sustainable business practices and sustainability investing by providing a fully […]

“LEQEMBI” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in the United Arab Emirates

TOKYO and CAMBRIDGE, Mass., Aug 14, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI®” (lecanemab) for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI […]